CEO Chris Haigh of Dakshidin Corp., talks about the recent acquisition of Whitechapel and coming name change, entering the CBD market with targeted therapies, and recent purchase of Runnymede Farms.
CEO Chris Haigh of Dakshidin Corp., talks about the recent acquisition of Whitechapel, scientific formulations, and licensing agreement with GenBio.
CEO Joe Moscato of Generex Biotechnology Corp., gives an update on recent acquisitions, bringing products to market, and plans for growth in 2019.
CEO Joe Moscato of Generex Biotechnology Corp., talks about research, development, and commercialization of drug delivery systems and technologies